Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Onconova Therapeutics, Inc. (ONTX)  
$0.73 0.00 (0.00%) as of 4:30 Thu 5/20


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 179,650,000
Market Cap: 131.14(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.73 - $0.73
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Onconova Therapeutics is a biopharmaceutical company focused on discovering and developing small molecule product candidates primarily to treat cancer. Co. has three clinical-stage product candidates and preclinical programs. Substantially all of Co.'s effort is focused on its primary product candidate, rigosertib, which has been tested in an intravenous formulation as a single agent for patients with higher-risk myelodysplastic syndromes (MDS), and an oral formulation as a single agent in lower risk MDS or in combination with azacitidine for patients with higher-risk MDS. Co.'s other product candidate, Briciclib, is a small molecule targeting an intracellular regulatory protein, Cyclin D1.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-29 2023-11-28 2023-05-30 2022-05-30

   
Records found: 181
  Page 7 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Michael & Jane Hoffman 2013 Descendants 10% Owner   –       –       •   2013-11-15 4 B $11.95 $236,265 D/D 19,700 4,307,500 2.45     -
   Kumar Ramesh President and CEO   •       •      –    2013-11-15 4 B $12.02 $13,222 D/D 1,100 276,500 2.81     -
   Bienen Henry S Director   –       •      –    2013-11-15 4 B $12.09 $17,038 D/D 1,400 14,935 2.39     -
   Altland James SVP, Finance & Corp. Develop.   •       –      –    2013-10-10 4 OE $6.00 $30,000 D/D 5,000 10,000     -
   Altland James SVP, Finance & Corp. Develop.   •       –      –    2013-07-30 4 OE $6.00 $30,000 D/D 5,000 5,000     -
   Michael & Jane Hoffman 2013 Descendants 10% Owner   –       –       •   2013-07-30 4 B $15.00 $15,000,000 D/D 1,000,000 4,287,800 2.45     -
   Michael & Jane Hoffman 2013 Descendants 10% Owner   –       –       •   2013-07-30 4 A $0.00 $0 D/D 2,643,140 3,287,800     -
   Mehta Viren Director   –       •      –    2013-07-30 4 A $0.00 $0 I/I 18,084 1,733     -
   Mehta Viren Director   –       •      –    2013-07-30 4 B $15.00 $250,005 D/D 16,667 126,914 2.39     -
   Mehta Viren Director   –       •      –    2013-07-30 4 A $0.00 $0 D/D 98,607 110,247     -
   Hoffman Michael B Director   –       •       •   2013-07-30 4 B $15.00 $15,000,000 I/I 1,000,000 4,372,330 2.25     -
   Hoffman Michael B Director   –       •       •   2013-07-30 4 A $0.00 $0 I/I 2,727,670 3,372,330     -
   Reddy E Premkumar Director   –       •      –    2013-07-30 4 B $15.00 $300,000 D/D 20,000 1,272,718 2.39     -
   Reddy E Premkumar Director   –       •      –    2013-07-30 4 A $0.00 $0 D/D 65,093 1,252,718     -
   Kumar Ramesh President and CEO   •       •      –    2013-07-30 4 B $15.00 $100,005 D/D 6,667 275,400 2.81     -
   Kumar Ramesh President and CEO   •       •      –    2013-07-30 4 A $0.00 $0 D/D 25,785 268,733     -
   Bienen Henry S Director   –       •      –    2013-07-30 4 B $15.00 $100,005 D/D 6,667 13,535 2.39     -
   Bienen Henry S Director   –       •      –    2013-07-30 4 A $0.00 $0 D/D 6,868 6,868     -
   Bansal Ajay Chief Financial Officer   •       –      –    2013-07-30 4 A $0.00 $0 D/D 23,785 43,846     -
   Baxter International Inc 10% Owner   –       –       •   2013-07-30 4 B $15.00 $4,950,000 D/D 330,000 2,603,295 2.45     -
   Baxter International Inc 10% Owner   –       –       •   2013-07-30 4 A $0.00 $0 D/D 2,273,295 2,273,295     -
   Mckearn Thomas J President, R&D   •       –      –    2013-07-30 4 B $15.00 $49,995 D/D 3,333 3,333 2.74     -
   Reddy E Premkumar Director   –       •      –    2013-07-25 4 B $22.71 $22,724 D/D 1,000 1,273,718 2.39     -
   Hoffman Michael B Director   –       •       •   2013-07-24 3 IO $0.00 $0 I/I 0 644,660     -
   Michael & Jane Hoffman 2013 Descendants 10% Owner   –       –       •   2013-07-24 3 IO $0.00 $0 D/D 0 644,660     -

  181 Records found
  1  2  3  4  5  6  7  8   
  Page 7 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed